View Author
scopus: 7005466793

Pons, D.

(Douwe Pons)


restenosi polymorphism patient study haplotype netherland factor center effect association allele department leiden analysis -10 disease result stent university cardiology heart genotype leiden university gender il -10 gene block signi syndrome level table frequency target vessel revascularization population target à2481 model diabetes gender study promoter artery protein region event receptor il -10 polymorphisms p 2y gene à2481 c allele mmp 2 vessel follow-up mmp 3 expression intervention variation mortality plasminogen activator inhibitor 298asp ficant month glu 298asp polymorphism vitamin nos 3 polymorphisms transcription matrix vdr gene chd death percutaneou woscop -949 regression nitric il -10 group monraat signi ficant association 3 gene polymorphisms oxide genotyping nos 3 gene signi ficantly




8 Most Recent Publications

Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality (Article)
Verschuren, J.J.W. Doevendans, P.A. Zwinderman, A.H. Trompet, S. Craen, Anton J.M. de Westendorp, R.G.J. Ikram, M.A. Tio, R.A. Kanse, Sandip M Winter, R.J. de Jukema, J.W. Slagboom, P.E. Pons, D.
2011-01-01
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: Evidence for a new concept from three independent prospective studies (Article)
Pons, D.
2011-01-01
Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis? (Article)
Verschuren, J.J.W. Sampietro, M.L. Maat, M.P.M. de Doevendans, P.A. Jukema, J.W. Pons, D. Trompet, S. Ewing, M.M. Quax, P.H.A. Knijff, P. de Zwinderman, A.H. Winter, R.J. de Tio, R.A.
2010-12-01
Vitamin D receptor: A new risk marker for clinical restenosis after percutaneous coronary intervention (Article)
Monraats, P.S. Fang, Y. Waltenberger, J. Frants, R.R. Quax, P.H.A. Laarse, A. van der Wall, E.E. van der Uitterlinden, A.G. Jukema, J.W. Pons, D. Pires, N.M.M. Pols, H.A.P. Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Dewinter, R.J. Tio, R.A.
2010-03-01
Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention: A study in patients with and without the metabolic syndrome (Article)
Pons, D. Monraats, P.S. Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Winter, R.J. de Tio, R.A. Waltenberger, J. Jukema, J.W.
2009-07-31
Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions (Article)
Rudež, G. Pons, D. Jukema, J.W. Leebeek, F.W.G. Monraats, P.S. Schrevel, M. Zwinderman, A.H. Winter, R.J. de Tio, R.A. Doevendans, P.A. Maat, M.P.M. de
2008-03-01
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions (Article)
Pons, D. Monraats, P.S. Winter, R.J. de Tio, R.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Maat, M.P.M. de Pires, N.M.M. Quax, P.H.A. Vlijmen, B.J.M. van Rosendaal, F.R. Zwinderman, A.H. Doevendans, P.A. Waltenberger, J.
2007-12-01
Interleukin 10: A new risk marker for the development of restenosis after percutaneous coronary intervention (Article)
Monraats, P.S. Kurreeman, F.A.S. Waltenberger, J. Huizinga, T.W.J. Eefting, D. Quax, P.H.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Pons, D. Sewgobind, V.D.K.D. Vries, F.R. de Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Winter, R.J. de Tio, R.A.
2007-01-01